Australia Urology Surgery Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 DBMR VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 HEALTHCARE EXPENDITURE WITH A FOCUS ON UROLOGY SURGERY

4.3.1 CYSTOSCOPY (SMALL BLADDER TUMOUR RESECTION)

4.3.2 TOTAL PROSTATECTOMY

4.3.3 TRANSRECTAL PROSTATE BIOPSY

4.3.4 PARTIAL NEPHRECTOMY

4.3.5 VISUAL LASER ABLATION (REMOVAL OF TISSUE FOR ENLARGED PROSTATE)

4.4 UROLOGY SURGERY PROCEDURE VOLUME TRENDS:

5 EPIDEMIOLOGY

6 AUSTRALIA UROLOGY SURGERY MARKET: REGULATIONS

6.1 REGULATORY AUTHORITIES IN THE AUSTRALIA-

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING INCIDENCE OF UROLOGICAL DISORDERS

7.1.2 INCREASE IN THE AGING POPULATION

7.1.3 GOVERNMENT INITIATIVES AND HEALTHCARE POLICIES

7.2 RESTRAINTS

7.2.1 SHORTAGE OF SPECIALIZED PROFESSIONALS

7.2.2 COMPLEXITY OF THE SURGICAL PROCEDURES

7.3 OPPORTUNITIES

7.3.1 TECHNOLOGICAL INNOVATIONS IN UROLOGICAL PROCEDURES

7.3.2 INCREASE IN VASECTOMY RATES IN AUSTRALIA

7.3.3 EXPANDING UROLOGY AWARENESS CAMPAIGNS

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS

7.4.2 POST-SURGICAL COMPLICATIONS

8 AUSTRALIA UROLOGY SURGERY MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PROSTATE BIOPSY

8.3 KIDNEY PARTIAL NEPHRECTOMY

8.3.1 EARLY-STAGE RENAL CELL CARCINOMA

8.3.2 BENIGN KIDNEY TUMORS

8.4 OTHERS

9 AUSTRALIA UROLOGY SURGERY MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 LAPAROSCOPIC SYSTEMS FOR KIDNEY SURGERIES

9.3 MRI/ULTRASOUND FUSION TECHNOLOGY FOR PROSTATE BIOPSIES

9.4 ROBOTIC-ASSISTED SURGICAL SYSTEMS

9.5 ABLATION TECHNOLOGIES

9.6 OTHERS

10 AUSTRALIA UROLOGY SURGERY MARKET, BY PROCEDURE

10.1 OVERVIEW

10.2 LAPAROSCOPIC SURGERY

10.3 ROBOTIC-ASSISTED SURGERY

10.4 OPEN SURGERY

11 AUSTRALIA UROLOGY SURGERY MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 UROLOGY SPECIALTY CLINICS

11.4 OTHERS

12 AUSTRALIA UROLOGY SURGERY MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: AUSTRALIA

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 BOSTON SCIENTIFIC CORPORATION

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENT

14.2 SIEMENS HEALTHINEERS AG

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENT

14.3 COOK

14.3.1 COMPANY SNAPSHOT

14.3.2 PRODUCT PORTFOLIO

14.3.3 RECENT DEVELOPMENT

14.4 OLYMPUS CORPORATION

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENT

14.5 STRYKER

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.6 GE HEALTHCARE

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 INTUITIVE SURGICAL OPERATIONS, INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 JOHNSON & JOHNSON SERVICES, INC

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENTS

14.9 MEDTRONIC

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS